PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
For detailed information, please view our study website: https://pearltrial.ucsf.edu/ The investigators aims to determine the the maternal and fetal safety and feasibility of in utero fetal enzyme replacement therapy in fetuses with Lysosomal Storage Diseases.
Live male or female fetuses at 18 0/7 weeks to 34 6/7 weeks gestation [+4]
Fetuses with a concurrent severe structural anomaly [+10]